Consequences attributed to poorly controlled and recurrent MDD are evaluated by Michael Rothrock, MBA, MHA, and H. Eric Cannon, PharmD, FAMCP. Michael Rothrock, MBA, MHA: The potential consequences of ...
—Being able to distinguish between recurrent and nonrecurrent depression subtypes around the time of the onset would allow both acute-phase therapies and prevention strategies to become more focused ...
MedPage Today on MSN
Fish Oil Flopped for Kids With Major Depressive Disorder
Adding a daily fish oil supplement to psychotherapy showed no significant benefit over placebo for kids and teens with ...
An analysis of major depressive disorder, covering diagnostic criteria, prevalence statistics across demographics, and ...
Although antidepressants are a mainstay of MDD treatment, they are plagued by poor efficacy, high rates of relapse, and intolerable side effects. 40,41 Second-generation antidepressants, including ...
Payers provide insights to health care disparities currently impacting patients with major depressive disorder (MDD). Jay Weaver, PharmD, MPH: When we’ve looked at health equity and disparities in ...
October is National Depression Screening Month, and this series of posts will focus on identifying and understanding the palette of variation in major depressive disorder (MDD). In the United States, ...
Major depressive disorder (MDD) is a specific health condition that causes symptoms of depression. If your symptoms get worse or last longer than 2 weeks, you should speak with a doctor. Major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback